Monday, 04 Sep 2023 | Funding Deadline
The aim of the competition is to accelerate innovations in dementia biomarker detection to transform clinical trials and precision therapies. This will be achieved by the development of or repurposing of technologies that will enable the robust detection of emerging dementia clinical biomarkers. The application of innovations in wet biomarkers, data, and tools and services, will feed into and support the aims of the UK government’s Dame Barbara Windsor dementia mission.
Deadline for proposals: 4 September 2023
Find out more here